Company name: Green Tree Therapeutics
Description: Distributor of therapeutic vaporizers. The company’s therapeutic vaporizers offers therapeutic benefits in the delivery of beneficial CBD and THC extracts, in addition it offers alternate cannabis products, including capsules, oils, and lotions, enabling clients to avail quality cannabis products and therapeutic vaporizers.
Industry: Healthcare | Group: Healthcare Devices and Supplies | Code:
State: British Columbia
Start up capital raised (USD Million):
Business status: Profitable
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million) 4.77
Earnings before interest, tax, depreciation and amortization (EBITDA): 4.77
Fiscal period: TTM 3Q2018
Financing Status: The company was acquired by Abattis Bioceuticals (CNQ: ATT) for an undisclosed amount on January 24, 2018. With this acquisition, Abattis will have the opportunity to vertically integrate its supply chain from extracts right through to retail.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 2.48
Last known valuation date: 31-May-2017